admin, Author at PsyNews.com

Home Authors Posts by admin

2168 POSTS 0 COMMENTS

https://psynews.com

The Psychedelic Drug Development Pipeline: Bullseye Chart Year-End 2023

PT484 – Seeing Through the Smoke: The Importance of Telling the...

PT483 – Traumatic Brain Injuries, the Gut Microbiome, and the Potential...

A Discussion with Ernesto Londoño, Author of “Trippy: The Peril and...

Caught in the Act: A Chemist’s Battle Against Felony Drug Charges

Interview: Compass Pathways CEO Kabir Nath Discusses Commercialisation, ‘Psychological Support’ and...

PT482 – Behind the Scenes: A Conversation on Psychedelic Business, Media,...

Magic Mushroom Formulations Update

Psychedelic Policy Reform & Legal Markets in 2023

Colorado Department of Revenue Natural Medicine Division Listening Sessions: Round 2

1...303132...217 Page 31 of 217

EDITOR PICKS

Pα+ Psychedelic Bulletin #185: Joe Rogan on Ibogaine; Wisconsin Medicaid to...

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing

Can Legalization Serve the Greater Good? The Ethical Challenges of Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin